Early cellular inflammation and neoplasia control.
D001151:Arsenic / Q000627:therapeutic use; D002273:Carcinogens; D002738:Chloroquine / Q000009:adverse effects / Q000627:therapeutic use; D005499:Folliculitis / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology; D007239:Infections / Q000150:complications; D007249:Inflammation / Q000150:complications; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*; D011565:Psoriasis / Q000188:drug therapy / Q000209:etiology; D012877:Skin Manifestations; D013638:Tars / Q000627:therapeutic use; D026681:Vitamin B 6 Deficiency / Q000150:complications
D002273:Carcinogens; D013638:Tars; D002738:Chloroquine; D001151:Arsenic